I
IOVA
Iovance Biotherp
4.100
-0.010-0.24%After Hours: 4.125 +0.025 +0.60%19:30 05/26 EDT
OPEN/PREV CLOSE4.075/4.110
TODAY RANGE3.950-4.250
VOL14.58M
MARKET CAP1.83B
52 WEEK RANGE1.660-5.63
AVG VOL (3M)15.94M
% TURNOVER3.27%
TURNOVER--
P/E (TTM)-4.3167
% RANGE7.30%
EPS(TTM)-0.9498
P/E(FORWARD)-7.9612
P/B2.489
BVPS1.647
DIVIDEND--
P/S6.41
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.71B
SHARES OUTSTANDING446.50M
NEXT EARNINGS08/05-08/10
FREE FLOAT416.08M
LOT SIZE1
EX-DATE09/26/2013
News
Press Releases
Financial Reports
Profile
TipRanks·05/15 16:30
Iovance’s Terminated TIL Study Reshapes Expectations for Solid-Tumor Growth
Seeking Alpha·05/11 13:57
FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
TipRanks·05/09 01:28
Iovance Biotherapeutics Signals Strong Momentum in Call
Seeking Alpha·05/08 14:58
Iovance Therapeutics: Q1 Earnings Miss May Have Created A Buying Opportunity
TipRanks·05/08 09:47
Barclays Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)
Dow Jones·05/08 00:22
Iovance Biotherapeutics Is Maintained at Buy by Chardan Capital
TipRanks·05/08 00:11
Iovance Biotherapeutics price target lowered to $14 from $16 at Chardan
Seeking Alpha·05/07 21:22
Iovance outlines $350M-$370M 2026 revenue, while guiding Q2 total revenue to $86M-$88M
Reuters·05/07 17:50
BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Same Industry
Name/Symbol
Change%
Price